Indegene Limited Stock

Equities

INDGN

INE065X01017

Business Support Services

Market Closed - NSE India S.E. 07:40:47 2024-05-23 am EDT 5-day change 1st Jan Change
533.5 INR +1.78% Intraday chart for Indegene Limited -5.84% 0.00%
Sales 2022 16.65B 200M Sales 2023 23.06B 277M Capitalization 117B 1.4B
Net income 2022 1.65B 19.79M Net income 2023 2.66B 31.96M EV / Sales 2022 * -
Net cash position 2022 * - 0 Net cash position 2023 * - 0 EV / Sales 2023 * -
P/E ratio 2022 *
-
P/E ratio 2023 *
-
Employees 5,181
Yield 2022 *
-
Yield 2023 *
-
Free-Float 99%
More Fundamentals * Assessed data
Dynamic Chart
1 week
521.30
Extreme 521.3
575.80
1 month
452.00
Extreme 452
660.00
Current year
452.00
Extreme 452
660.00
1 year
452.00
Extreme 452
660.00
3 years
452.00
Extreme 452
660.00
5 years
452.00
Extreme 452
660.00
10 years
452.00
Extreme 452
660.00
More quotes
Indegene Limited is a life sciences commercialization company. It provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its Omnichannel Activation solutions help life sciences companies leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. Its Enterprise Commercial Solutions primarily involves assisting life sciences companies with their digital marketing operations. Under its Enterprise Medical Solutions, it establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. It also offers enterprise clinical solutions and consultancy services.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
533.5
Average target price
-
Consensus